Center for Scientific Review; Notice of Closed Meeting, 43994 [2010-18387]
Download as PDF
<![CDATA[
43994
Federal Register / Vol. 75, No. 143 / Tuesday, July 27, 2010 / Notices
treatment programs and practice. Additional
agenda items include a perspective from the
Veterans Health Administration and an
opportunity to discuss the implications of
Healthy People 2020. The meeting will afford
Committee members with the opportunity to
discuss the current healthcare workforce
issues in an effort to formulate
recommendations for the Secretary and the
Congress.
Agenda: The ACICBL agenda includes an
overview of the Committee’s general business
activities, along with a number of
presentations that will include Healthy
People 2020, chronic illness management,
integrating programs to manage health
behaviors, and financing issues.
Recommendations will be formulated for
inclusion in the Tenth Annual Report of the
ACICBL. Agenda items are subject to change
as dictated by the priorities of the Committee.
Supplementary Information: Requests to
make oral comments or to provide written
comments to the ACICBL should be sent to
Dr. Joan Weiss, Designated Federal Official at
the contact information below. Individuals
who plan to attend the meeting and need
special assistance should notify Dr. Weiss at
least 10 days prior to the meeting, using the
address and phone number below. Members
of the public will have the opportunity to
provide comments at the meeting.
For Further Information Contact: Anyone
requesting information regarding the ACICBL
should contact Dr. Joan Weiss, Designated
Federal Official with the Bureau of Health
Professions, Health Resources and Services
Administration, Parklawn Building, Room 9–
36, 5600 Fishers Lane, Rockville, Maryland
20857, (301) 443–6950 or jweiss@hrsa.gov. In
the absence of Dr. Weiss, CAPT Norma J.
Hatot, Senior Nurse Consultant, can be
contacted via telephone at (301) 443–2681 or
e-mail at nhatot@hrsa.gov.
Dated: July 20, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2010–18258 Filed 7–26–10; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on DSKD5P82C1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
VerDate Mar<15>2010
17:49 Jul 26, 2010
Jkt 220001
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cancer Therapeutics.
Date: August 4, 2010.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Syed M. Quadri, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 20, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–18387 Filed 7–26–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the National Advisory
Council for Complementary and
Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine.
Date: September 3, 2010.
Closed: September 3, 2010, 8:30 a.m. to
10:30 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Neuroscience Building, 6001 Executive
Boulevard, Conference Rooms C & D,
Bethesda, MD 20892.
Open: September 3, 2010, 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director
of the National Center for Complementary
and Alternative Medicine, presentation of a
new research initiative, and other business of
the Council.
Place: National Institutes of Health,
Neuroscience Building, 6001 Executive
Boulevard, Conference Rooms C & D,
Bethesda, MD 20892.
Contact Person: Martin H. Goldrosen, PhD,
Executive Secretary, Director, Division of
Extramural Activities, National Center for
Complementary and Alternative Medicine,
National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, (301) 594–2014.
The public comments session is scheduled
from 3:30 to 4 p.m. on September 3, 2010, but
could change depending on the actual time
spent on each agenda item. Each speaker will
be permitted 5 minutes for their presentation.
Interested individuals and representatives of
organizations are requested to notify Dr.
Martin H. Goldrosen, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Boulevard, Suite 401,
Bethesda, Maryland 20892, 301–594–2014,
Fax: 301–480–9970. Letters of intent to
present comments, along with a brief
description of the organization represented,
should be received no later than 5 p.m. on
August 26, 2010. Only one representative of
an organization may present oral comments.
Any person attending the meeting who does
not request an opportunity to speak in
advance of the meeting may be considered
for oral presentation, if time permits, and at
the discretion of the Chairperson. In
addition, written comments may be
submitted to Dr. Martin H. Goldrosen at the
address listed above up to ten calendar days
(September 13, 2010) following the meeting.
Copies of the meeting agenda and the
roster of members will be furnished upon
request by contacting Dr. Martin H.
Goldrosen, Executive Secretary, NACCAM,
National Center for Complementary and
Alternative Medicine, National Institutes of
Health, 6707 Democracy Boulevard, Suite
401, Bethesda, Maryland 20892, 301–594–
2014, Fax 301–480–9970, or via e-mail at
naccames@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and sign-
E:\FR\FM\27JYN1.SGM
27JYN1
]]>Agencies
[Federal Register Volume 75, Number 143 (Tuesday, July 27, 2010)]
[Notices]
[Page 43994]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18387]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Cancer Therapeutics.
Date: August 4, 2010.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call)
Contact Person: Syed M. Quadri, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301-435-
1211, quadris@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: July 20, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-18387 Filed 7-26-10; 8:45 am]
BILLING CODE 4140-01-P
